The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Changes in T Lymphocyte Subsets and Cytokine Levels in Patients with Chronic Hepatitis B before and after Treatment
Author(s): 
Pages: 803-805
Year: Issue:  6
Journal: JOURNAL OF JILIN UNIVERSITY(MEDICINE EDITION)

Keyword:  肝炎乙型慢性/治疗干扰素α/治疗应用T淋巴细胞亚群细胞因子类;
Abstract: 目的:探讨干扰素α(赛若金)治疗慢性乙型肝炎(乙肝)疗效与机体免疫状态的关系.方法:采用抗体致敏的红细胞花环试验及双抗体夹心酶联免疫吸附测定(ELISA)大剂量干扰素α治疗前后乙肝患者T淋巴细胞亚群CD4+、CD8+及CD4+/CD8+、IL-10、IL-12、TNF-α含量.结果:干扰素α治疗前T淋巴细胞亚群CD4+、CD8+、CD4+/CD8+比值及IL-10、IL-12和TNF-α含量分别为(39.91±4.52)%、(34.13±4.24)%、(1.13±0.12)%及(30.61±11.21)pg*L-1、(58.12±13.52)pg*L-1和(265.83±60.63)pg*L-1,治疗6个月后治疗有效组分别为(43.12±4.31)%、(30.81±5.13)%、(1.41±0.11)%及(16.51±8.63)pg*L-1、(92.93±21.52)pg*L-1、(126.92±53.83)pg*L-1.结论:大剂量干扰素α治疗后慢性乙型肝炎患者抗病毒免疫状态明显增强.
Related Articles
loading...